US Patent 11390674 Anti-TIM-3 antibodies and compositions
Patent 11390674 was granted and assigned to Symphogen on July, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Gunther Roland Galler0
Ivan David Horak0
Klaus Koefoed0
Michael Kragh0
Michael Monrad Grandal0
Mikkel Wandahl Pedersen0
Monika Gad0
Thomas Bouquin0
Torben Gjetting0
Trine Lindsted0
Edits on 22 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 20 Jul, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+146 characters)
US Patent 11390674 Anti-TIM-3 antibodies and compositions
Article
This invention relates to anti-TIM-3 antibodies and antibody compositions and their use in enhancing immunity in a patient, e.g., to treat cancer.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11390674
Date of patent
July 19, 2022
Patent application number
16093024
Date Filed
April 11, 2017
Patent citations
Patent primary examiner
Find more entities like US Patent 11390674 Anti-TIM-3 antibodies and compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.